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Department of Biological Sciences, Virginia Tech, Blacksburg, VirginiaABSTRACT Epithelial to mesenchymal transition (EMT) plays an important role in embryonic development, tissue regenera-
tion, and cancer metastasis. Whereas several feedback loops have been shown to regulate EMT, it remains elusive how they
coordinately modulate EMT response to TGF-b treatment. We construct a mathematical model for the core regulatory network
controlling TGF-b-induced EMT. Through deterministic analyses and stochastic simulations, we show that EMT is a sequential
two-step program in which an epithelial cell first is converted to partial EMT then to the mesenchymal state, depending on the
strength and duration of TGF-b stimulation. Mechanistically the system is governed by coupled reversible and irreversible bista-
ble switches. The SNAIL1/miR-34 double-negative feedback loop is responsible for the reversible switch and regulates the initi-
ation of EMT, whereas the ZEB/miR-200 feedback loop is accountable for the irreversible switch and controls the establishment
of the mesenchymal state. Furthermore, an autocrine TGF-b/miR-200 feedback loop makes the second switch irreversible,
modulating the maintenance of EMT. Such coupled bistable switches are robust to parameter variation and molecular noise.
We provide a mechanistic explanation on multiple experimental observations. The model makes several explicit predictions
on hysteretic dynamic behaviors, system response to pulsed stimulation, and various perturbations, which can be straightfor-
wardly tested.INTRODUCTIONEpithelial to mesenchymal transition (EMT) is defined as
the conversion of epithelial cell to mesenchymal cell, char-
acterized by loss of cell-cell adhesion and increased cell
motility (1,2). EMT plays important roles in embryonic
development and tissue regeneration (2,3). In addition, inap-
propriate utilization of EMT may lead to pathological pro-
cesses, such as fibrosis and cancer metastasis (3). Thus, in
both physiological and pathological contexts, understanding
the regulation of EMT process is fundamental for prevention
and treatment of cancer metastasis and organ-degenerative
diseases.
EMT can be induced by a plethora of stimuli, of which
transforming growth factor-b (TGF-b) is a major and very
potent inducer (4). Several crucial transcription factors are
involved in a TGF-b mediated EMT, including SNAIL1/2
and ZEB1/2. They directly repress the expression of the
epithelial state (E state) marker E-cadherin, while promot-
ing the induction of the mesenchymal state (M state) marker
N-cadherin (3). Several miRNAs also are involved in regu-
lating EMT, of which miR-34 and miR-200 are the most
studied (5). Moreover, the transcription factors and miRNAs
are linked by several feedback loops. One is the double-
negative feedback loop between ZEB1/2 (collectively
referred to as ‘‘ZEB’’ thereafter) and the miR-200 family
(miR-200a, miR-200b, miR-200c, miR-141, and miR-
429), in which ZEB1/2 represses the expression of miR-
200 whereas miR-200 negatively regulates the translation
of ZEB1/2 (6–8). The other double-negative feedbackSubmitted May 8, 2013, and accepted for publication July 9, 2013.
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referred to as ‘‘miR-34’’ thereafter) in a similar way
(9,10). Furthermore, release of miR-200-mediated inhibi-
tion of TGF-b is required to maintain a stable mesenchymal
phenotype (11). That is, several coupled positive feedback
loops seemingly function redundantly to regulate the pro-
cess. It remains to be fully understood how these feedback
loops coordinately modulate EMT response to TGF-b
treatment.
EMT is classically viewed as a switch that converts the
static, ordered epithelia into labile, individual mesenchymal
cells. However, EMT is not always an all-or-none response.
In addition to the epithelial and mesenchymal states, reports
exist on an intermediate phenotype in the process of EMT,
known as the partial EMT (pEMT) state (12–16). The partial
EMT state retains some characteristics of epithelium but
also shows features of mesenchymal cells (17). Notably,
pEMT is a metastable, reversible phenotype (18), whereas
complete EMT is not. The existence of the epithelial,
pEMT, and mesenchymal states leads us to hypothesize
that complete EMT may be a sequential multistep program.
Then the question is how these three states are generated
from the regulatory network, and how partial EMT is revers-
ible whereas full EMT is irreversible.
Several mathematical models have been developed to
explore the dynamics of TGF-b signaling pathway in epithe-
lial mesenchymal transition (19–22). In contrast to these
two-compartment models, Vilar et al. built a trafficking-
coordinate model to accurately capture the distinct TGF-b
signaling dynamics (23). However, these models only focus
on the quantitative dynamic of Smad nucleo-cytoplasmic
shuttling and do not take into account the downstream ofhttp://dx.doi.org/10.1016/j.bpj.2013.07.011
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double-negative feedback loops. Thus, it remains to be
further elucidated how the cell fate is coordinately deter-
mined during TGF-b-induced EMT.
Motivated by the above consideration, in this work we
perform a systematic mathematical analysis on the core reg-
ulatory network for EMT, addressing the relation between
the network structure and its functional roles. In the remain-
ing sections, we will first present the network constructed by
integrating existing experimental studies, then discuss its
deterministic and stochastic dynamic behaviors in response
to exogenous TGF-b treatment and associate the network
dynamics with cellular outcomes. We conclude with discus-
sions on how the design of the network matches its
functional requirements, and propose future experimental
studies for testing the predictions from our simulation.MODEL AND METHODS
Fig. 1 gives a schematic diagram of the core regulatory network. Autocrine
or exogenous TGF-b promotes the expression of snail1 mRNA (24), which
is translated to SNAIL1 protein. SNAIL1 promotes the transcription of zeb,
which is translated to ZEB. Experimental studies reveal two core double-
negative feedback loops between transcription factors and miRNAs. The
first one is between SNAIL1 and miR-34 (9,10). SNAIL1 inhibits transcrip-
tion of miR-34, which represses translation of snail1, enclosing a double-
negative feedback loop. The other one is between ZEB and miR-200
(6–8). ZEB represses transcription of miR-200, which inhibits translation
of zeb, enclosing the other double-negative feedback loop. miR-200 also in-
hibits the autocrine expression of TGF-b (11), making another feedback
loop. As the marker of epithelial cells, E-cadherin is inhibited by SNAIL1
and ZEB, whereas the marker of mesenchymal cells N-cadherin is pro-
moted by SNAIL1 and ZEB (3). Table S1 in the Supporting Material
summarizes the experimental support of the regulatory network. We firstFIGURE 1 Schematic depiction of the core regulatory network. Exoge-
nous or endogenously expressed TGF-b promotes the expression of snail1
mRNA, which is translated to SNAIL1. SNAIL1 promotes the transcription
of zeb mRNA, which is translated to ZEB. SNAIL1 inhibits the expression
of miR-34, which represses the translation of snail1, forming a double-
negative feedback loop. ZEB represses the induction of miR-200, which in-
hibits the translation of zeb, forming another double-negative feedback
loop. The autocrine expression of TGF-b is also inhibited by miR-200.
As the marker of epithelial cell, E-cadherin is inhibited by SNAIL1 and
ZEB, whereas the marker of mesenchymal cell, N-cadherin, is promoted
by SNAIL1 and ZEB.
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ordinary differential equations, then study the effect of noises with stochas-
tic simulations. We use the following set of ordinary differential equations
to model the deterministic dynamics of the core regulatory network:
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where [T], [s], [S], [R3], [z], [Z], [R2], [E], and [N] denote the concentra-
tions of endogenous TGF-b, snail, SNAIL, miR-34, zeb, ZEB, miR-200,
E-cadherin, and N-cadherin, respectively. Regulation of the transcription
of each gene is characterized by the Hill function, which is often used to
represent the regulation of the transcription of an unknown gene (25,26).
Currently there is no experimental data on the response curve of the gene
expression level versus the transcription factor level. For simplicity, we
choose all the Hill coefficients to be 2 to allow sufficient nonlinearity.
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and a set of standard parameter values, respectively. The default state is
the epithelial phenotype, in which the concentration of each species is set
to its stable steady-state value in the absence of exogenous TGF-b treatment
(i.e., TGF0 ¼ 0).
Intrinsic noise that results from low copy numbers of mRNAs and
miRNAs per cell can affect all the biological processes (27). However, there
are some systems that can function deterministically even when the average
number of number of mRNA molecules is <1 (28). To investigate the sto-
chastic effects of the finite number of molecules on the dynamics of EMT
system, we also build a stochastic version of the model, which generally can
be described by birth-and-death stochastic processes governed by chemical
master equations. By introducing a system size factor U, we change the
concentration of each molecular to its number, i.e., xi ¼ [xi] , U. Table
S4 lists all the reactions involved. We use the t-leap-based stochastic
Gillespie algorithm to simulate the stochastic model (29,30). To account
for cell-to-cell variability in population level, we also add extrinsic noise
in the model as static parameter value variations. In these single-cell based
simulations, every parameter value of a cell is randomly and uniformly cho-
sen from 85 to 115% of its default value with Latin Hypercubic sampling.RESULTS
Epithelial to mesenchymal transition is a
sequential two-step program
Fig. 2 shows the deterministic dynamics of proteins and
miRNAs under different levels of constant exogenous
TGF-b treatment. There are two possible cell fates in
response to TGF-b treatment. When the level of the exoge-
nous TGF-b is limited, e.g., 1.8 units (ng/mL) (Fig. 2 A), the
mRNA of snail1 is induced quickly. However, SNAIL1 pro-
tein level does not go up until the repression of translationA B
FIGURE 2 Epithelial to mesenchymal transition is a sequential two-step
program. (A) The dynamics of partial EMT at 1.8 units treated with exog-
enous TGF-b. (B) The predicted (solid lines) and experimentally measured
(circles) dynamics of full EMT at 3.0 units treated with exogenous TGF-b.
The experimental data on the MDCK cell line is quantified from Bracken
et al. (7).mediated by miR-34 is removed later. Notably, the levels
of ZEB and miR-200 barely change throughout the time.
Furthermore, endogenous expression of TGF-b is not acti-
vated. E-cadherin is partially inhibited and N-cadherin is
partially activated. That is, the cell shows both epithelial
and mesenchymal traits, consistent with the experimentally
observed feature of partial EMT (17).
When the level of the exogenous TGF-b increases, e.g.,
3.0 units, the cell converts to a different cell type (see
Fig. 2 B). The network dynamics then undergoes a biphasic
response. In the early stage, SNAIL1 is expressed and miR-
34 is silenced. This induces partial inhibition of E-cadherin
expression and partial activation of N-cadherin expression,
and thus the cell reaches the pEMT state. In this case, the
exogenous TGF-b induces full expression of SNAIL1,
which then induces transcription of zeb. Again, the increase
of ZEB protein level is well delayed because of the transla-
tional repression mediated by miR-200. Eventual expression
of both SNAIL1 and ZEB induces full inhibition of E-cad-
herin expression and full activation of N-cadherin expres-
sion, and finally shifts the cell to the mesenchymal state.
Furthermore, the autocrine expression of TGF-b is activated
in the second phase after miR-200-mediated inhibition is
released. The predicted biphasic dynamics is in good
agreement with the experimental data, which is quantified
from Bracken et al. (7). A clearer biphasic dynamics can
be seen from the results with another human cell line
MCF10A, shown in Fig. S1 in the Supporting Material
where more time-course data points are available. Taken
together, EMT is a sequential two-step programming, first
to partial EMT and then to full EMT.The two-step dynamics of EMT results from
sequential activation of two bistable switches
Close examination of the network in Fig. 1 suggests that the
dynamics of EMT is governed by a cascade action of two
bistable switches: one shifts the cell to pEMT state and
the other triggers the cell to full EMT. This mechanism
can be clearly seen from the one-parameter bifurcation anal-
ysis in Fig. 3 A, which shows dependence of the steady
states of N-cadherin on the exogenous TGF-b level. There
are three distinct branches (solid lines) in the bifurcation
diagram, indicating existence of three types of stable steady
states: E (blue lower branch), pEMT (green middle branch),
and M (red upper branch). These three states are governed
by two bistable switches. Suppose that one cell originally
starts in the lower branch corresponding to the E state.
Upon gradually adding exogenous TGF-b, the N-cadherin
level jumps to the middle branch after it crosses the first sad-
dle-node bifurcation point SN1. That is, the cell is transited
to the pEMT state from the E state. While at the pEMT state,
if the exogenous TGF-b level decreases beyond another sad-
dle-node bifurcation point (SN2), the N-cadherin level shifts
back to low level corresponding to the E state. TheBiophysical Journal 105(4) 1079–1089
FIGURE 3 The biphasic EMT dynamics results from two coupled bista-
ble switches. (A) Bifurcation analysis of N-cadherin level versus the
exogenous TGF-b level. (B–D) Phase diagrams showing N-cadherin
maximum and end-point values for cells subjected to pulse treatment of
exogenous TGF-b with different values of strength and duration.
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the latter is larger than zero. That is, the transition from E to
pEMT state is governed by one reversible bistable switch.
When the level of exogenous TGF-b is larger than that at
SN3, the N-cadherin level is shifted to the upper branch
from the middle branch, i.e., the cell is transited to the M
state from the pEMT state. At the M state, the cell stays
on this state even if the exogenous TGF-b is removed.
Actually, there is another saddle-node bifurcation point
SN4 on the negative side of the axis, which cannot be
reached by the system physically. That is, the transition
from the pEMT to the M state is governed by one irrevers-
ible bistable switch.
Fig. 3, B–D, gives a full spectrum of the system dynamics
under pulsed exogenous TGF-b with values of different
strength and duration. The maximum level of N-cadherin
shows three regions in the plane of strength and duration
of exogenous TGF-b. Treatment of exogenous TGF-b in
the light-shaded (yellow online) region triggers the cell to
pEMT. However, the cell recovers back to E state after the
stimulus is withdrawn because the endpoint level of N-cad-
herin recovers to low level, showing the reversibility of par-
tial EMT. In contrast, the treatment of exogenous TGF-b in
the dark-shaded (red online) region triggers the cell to full
EMT and maintains it in the M state after the stimulus is
withdrawn, exhibiting the irreversibility of the full EMT.
Therefore, complete EMT requires both a minimal duration
and a minimal strength of TGF-b treatment.
To see whether this conclusion depends heavily on
parameter values, we perform parameter sensitivity analysis
to systematically explore how the features of two switches
change upon varying each of the 33 parameters in the feed-Biophysical Journal 105(4) 1079–1089back loops and the Hill coefficients. The variation of the pa-
rameters in the expression of E-cadherin and N-cadherin do
not change four thresholds. The thresholds for activation of
partial EMT and full EMT are the corresponding exogenous
TGF-b levels at SN1 and SN3, respectively. The revers-
ibility/irreversibility of partial/full EMT is determined by
the sign of the corresponding exogenous TGF-b level at
SN2/SN4. First from Fig. 4 A, all the four saddle-node
points are distributed around that under the standard param-
eter set when each parameter is increased or decreased by
15% with respect to the standard parameter set. Notably,
one sees that the corresponding exogenous TGF-b level at
SN2 is always positive whereas that at SN4 is always nega-
tive under this parameter variation. That is, the first switch is
robustly reversible whereas the second one is robustly irre-
versible with this degree of parameter variation.
We then further calculate the percentage of changes in
four thresholds in Fig. 4 B. The thresholds for the first switch
are sensitive to the parameters in the SNAIL1/miR-34 feed-
back loop, whereas the thresholds for the second switch are
sensitive to the parameters in both the SNAIL1/miR-34 and
ZEB/miR-200 feedback loops. Furthermore, SN4 is also
sensitive to the parameters associated with the autocrine
expression of TGF-b, implying the regulation of autocrine
TGF-b on the irreversibility of the second switch. We will
come back to this point later. In summary, the EMT network
has a robust basic feature of a reversible bistable switch
coupled to an irreversible bistable switch.Coupled positive feedback loops are responsible
for the two bistable switches
The above analysis demonstrates that the dynamics of EMT
is governed by two bistable switches. To reveal the underly-
ing mechanism for these two bistable switches, we examine
the dependence of steady-state levels of SNAIL1, miR-34,
ZEB, miR-200, and the endogenous TGF-b on the exoge-
nous TGF-b level, as shown in Fig. 5 A. When the exoge-
nous TGF-b level is less than that at SN1, the expression
level of SNAIL1 is low, and that of miR-34 is high. They
switch their dominance at SN1. The expression level of
SNAIL1 changes dramatically again at SN3. The miR-34
levels for the pEMT and M states are both very low and
hardly distinguishable. However, experimentally, if one
starts to reduce the exogenous TGF-b level, the system
initially at pEMT state can eventually jump back to the
high miR-34 level E state. On the other hand, the system
initially at M state will maintain a low miR-34 level.
In contrast, only the two bifurcation points at SN3 and
SN4 (in the negative side of axis) are easily detectable in
the signal response curves of ZEB, miR-200, and autocrine
TGF-b. When the exogenous TGF-b level is larger than
that at SN3, ZEB is expressed whereas miR-200 is
inhibited. That is, ZEB and miR-200 dominate alternatively
with the second switch on and off, respectively. Thus, the
A B
FIGURE 4 Parameter sensitivity of the two bistable switches. (A) The level of exogenous treatment of TGF-b at the four saddle-node bifurcation points
SN1~4 when each of 33 parameters in the coupled feedback loops and the Hill coefficients is increased or decreased by 15% with respect to the standard
parameter set. (B) Percentage of changes in the levels of exogenous TGF-b at SN1~4 compared to that with the standard parameter set.
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miR-200 feedback loop. Turning on the second switch
also activates the autocrine expression of TGF-b, which
amplifies the level of SNAIL1 to further level, and leads
to the four clear bifurcation points on the response curve
of SNAIL1.
It is well known that positive feedback loop is a basic
motif to function as a bistable switch (31–34). To further
investigate the correlation between two bistable switches
and SNAIL1/miR-34 and ZEB/miR-200 double-negative
feedback loops, Fig. 5 B shows the dependence of the two
thresholds for activation of partial EMT and full EMT on
the feedback strength of two loops. For simplicity, the
Michaelis constant of mutual inhibition between SNAIL1
and miR-34 (JSNAIL, J34) are chosen to characterize the
feedback strength of the first loop, whereas the Michaelis
constant of mutual inhibition between ZEB and miR-200
(JZEB, J200) are chosen to characterize the feedback strength
of the second loop. Both thresholds decrease with the in-
crease of JSNAIL while increasing with J34. That is, both
induction of partial EMT and full EMT can be regulated
by SNAIL1/miR-34 feedback loop. By contrast, only the
threshold for full EMT induction is regulated by the feed-back strength of the second loop. Thus, EMT is initiated
by Snail/miR-34 regulatory loop, and stabilized by ZEB/
miR-200 regulatory loop. This is consistent with experi-
mental report (11). Furthermore, activation of the second
switch depends on activation of the first switch. Taken
together, the two-step dynamics of EMT results from
sequential activation of two bistable switches, which are
governed by SNAIL/miR-34 and ZEB/miR-200 double-
negative feedback loops.Manipulation of the autocrine TGF-b modifies the
irreversibility of the full EMT
The results discussed above show that the autocrine expres-
sion of TGF-b is activated when the second bistable switch
is turned on. To further investigate the role of autocrine
expression of TGF-b on the dynamics of EMT, we perform
in silico experiments of adding a constant TGF-b expres-
sion inhibitor or miR-200 expression activator. Fig. 6 A
shows that the thresholds SN1~3 barely change with the
inhibitor level. On the other hand, the threshold for the
deactivated of the second bistable switch (SN4) changes
from negative to positive with increasing the inhibitor level.Biophysical Journal 105(4) 1079–1089
A B
FIGURE 5 Bifurcation analysis indicates that EMT is initiated by the
Snail1/miR-34 regulatory loop, and stabilized by the ZEB/miR-200 regula-
tory loop. (A) Bifurcation diagrams of SNAIL1, miR-34, ZEB, miR-200,
and endogenous TGF-b on the level of exogenous TGF-b. (B) Depen-
dencies of the thresholds for activation of partial EMT and full EMT on
the strength of the SNAIL1/miR-34 feedback loop (JSNAIL and J34) and
the strength of the ZEB/miR-200 feedback loop (JZEB and J200).
1084 Tian et al.The same goes for the dependence of SN4 on miR-200
activator level (see Fig. S2), an alternative way to per-
turbing TGF-b expression. That is, the second bistable
switch is turned to be reversible when the TGF-b inhibition
or miR-200 activation is large enough. The bifurcation di-
agrams in Fig. 6 B and Fig. S2 B clearly show this transi-
tion from an irreversible (wild-type) to a reversible
(mutant) switch.
Thus, the irreversibility of the second bistable switch is
only relative. It can be tuned by modulating signals in
addition to the exogenous TGF-b, explaining the stable
yet reversible feature of EMT. Taken together, release
of the inhibition of miR-200 on autocrine expression of
TGF-b is responsible for the irreversibility of the full0 0.02 0.04 0.06 0.08
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FIGURE 6 Irreversibility of full EMT is maintained by the endogenous
TGF-b expression. (A) Dependence of four bifurcation points on the level
of endogenous TGF-b expression inhibitor. (B) Bifurcation diagrams of
N-cadherin depending on the exogenous level of TGF-b for wild-type cells
(curves) and mutant cells (curves with circles) with inhibited endogenous
expression of TGF-b.
Biophysical Journal 105(4) 1079–1089EMT induction. This is consistent with experimental re-
sults that maintenance of a stable mesenchymal phenotype
requires the establishment of autocrine TGF-b signaling
(11). It should be noted that the irreversibility of the full
EMT is cell-type-dependent. It has been shown that the
transition to mesenchymal state is stabilized after pro-
longed exogenous TGF-b treatment in MDCK cells after
withdrawal of the TGF-b (11), but it cannot be sustained
long term after TGF-b is withdrawn in epithelial NMuMG
cells (35). The reason for this difference is presently not
well understood and needs further study. Our results sug-
gest one possibility is either reduced expression of auto-
crine TGF-b or overexpression of miR-200 in this cell
line compared to others.
The requirement of the autocrine expression of TGF-b
on the irreversibility of EMT indicates that the conversion
from mesenchymal to epithelial (MET) needs suppression
of endogenous TGF-b signaling by exogenous factors to
prevent self-perpetuation of EMT. Actually, during the
initiation phase of reprogramming of mouse fibroblasts,
exogenous factors OSKM (Oct4, Sox2, Klf4, Myc) suppress
TGF-b signaling (36), both Oct4/Sox2 and BMP can
directly activate miR-200 to induce MET (37,38). These
results are consistent with our finding here that it needs
to turn the second bistable switch to be reversible for
induction of MET by inhibiting the autocrine expression
of TGF-b. Interestingly, a partial MET state exists in the
transition from the M to the EMT state (see Fig. S3).
Consistently, there is one experimental report on the partial
MET state (39).Influences of the intrinsic and extrinsic noise on
the epithelial to mesenchymal transition
Cells face various kinds of uncertainties, such as intrinsic
noises and extrinsic variations. The intrinsic noises come
from low numbers of molecules per cell, such as miRNAs
in our model, whereas the extrinsic noises result from
parameter variations due to fluctuations of the environment
including other cellular components. They generate pheno-
typic heterogeneity at the population level.
Fig. 7 A shows 50 typical simulated stochastic trajectories
of cells at 2 units of exogenous TGF-b. The biphasic
dynamics survives inclusion of noises, although the level
of N-cadherin in pEMT state and M state varies from cell
to cell. It is noted that the backward transition from the
pEMT to the E state in Fig. 7 A is very rare. This asymmetry
of forward and backward transition rates is related to hyster-
esis, a prominent property of a bistable system. That is, the
required TGF-b concentration to induce the forward transi-
tion is higher than that to induce the backward transition.
Since we choose a TGF-b concentration that favors
forward transition, the backward transition rate is very low
under this level of noise. Indeed, if we consider that the
exogenous concentration of TGF-b fluctuates (so it can be
FIGURE 7 Influence of the intrinsic and extrinsic noises on the epithelial
to mesenchymal transition. (A) N-cadherin dynamics of 50 cells from sto-
chastic stimulation. (B) Distribution of the time for transition to partial
EMT TpEMT and that for transition to mesenchymal state TEMT. (C) The per-
centage of cell fates as a function of time. (D) N-cadherin distribution at
different time points. The exogenous level of TGF-b treatment is 2.0.
Modeling Epithelial to Mesenchymal Transition 1085close to SN1 or SN2 at different times), as shown in Fig. S5,
one can observe more frequent forward/backward transi-
tions between the pEMT state and the E state.
More prominent cell-to-cell variation is the time a cell is
converted to pEMT, denoted as TpEMT, and the time of tran-
sition to M state, TEMT. Both the distributions of TpEMT and
TEMT, especially that of TEMT, show broad distributions
either when incorporating extrinsic and intrinsic noise
(Fig. 7 B) or only intrinsic noise (see Fig. S4). This is consis-
tent with the sensitivity analysis in Fig. 4: the threshold for
activation of full EMT (SN3) is more sensitive to parameter
variation than the threshold for activation of pEMT (SN1).
The time evolution of each subpopulation in Fig. 7 C
shows typical three-state dynamics at 2 units of TGF-b.
Starting with cells in the epithelial state, the E state cell per-
centage drops monotonically, the pEMT fraction firstly in-
creases then decreases, leading to an increase of M state
cells. The pEMT and M state cells coexist after a long
time because the TGF-b concentration is within the bistable
region. We note that even at the end of the simulation,
20 days, a significant portion of cells remain in the E state,
which is beyond the expectation from a simple exponential
decay dynamics. The evolution over time is more clearly
seen from the snapshots in Fig. 7 D. The 2000 simulated
cells initially have a narrow distribution centered at low
N-cadherin levels, then gradually another peak with
medium N-cadherin level appears and grows to dominate
over the low N-cadherin peak, followed by appearance of
the third peak with high N-cadherin levels. One can exper-
imentally test on these dynamic behaviors using flow cytom-
etry measurements.DISCUSSION
The core regulatory network is designed to be
robust against fluctuations and response
differentially to signals with different strength and
duration
Epithelial cells form the densely packed top layer of cav-
ities, glands, and other structures throughout the body.
Each individual cell adheres to its neighbors tightly and is
immobile. On the other hand, mesenchymal cells are loosely
connected to each other, and thus easy to move. Conversion
between these two distinct phenotypes requires global
change of the transcription program (3), and is expected to
be tightly regulated to prevent inadvertent transitions. At
certain physiological conditions, such as wound healing,
however, some epithelial cells need to respond to certain
stimuli, migrate to the target site, and then convert back to
epithelial cells after the stimulus has been removed, e.g.,
after the wound healing process is finished. Therefore, the
regulatory network has the combined functional require-
ments of being both robust against stochastic fluctuations
and flexible to convert between the immobile and migratory
phenotypes reversibly.
Our analyses in this work suggest that the EMT core reg-
ulatory network has evolved in several aspects to achieve the
above requirements. The basic structure of the network is a
cascade of two self-activation motifs. Each of the motifs
serves as a bistable switch, with the end product of the first
one, SNAIL1, serving as the trigger for the second switch.
This allows the existence of an intermediate state, the partial
EMT state, with only the first switch turned on, at interme-
diate stimulus strength and duration, as shown in Fig. 2 A
and Fig. 3. Fig. 8 summarizes the overall picture of the
whole process. Upon removal of the external stimulus,
this partial EMT state switches back to the epithelial state
because no mechanism exists to sustain the state. The two
switches are further connected by a miR-200/TGF-b medi-
ated positive feedback. Consequently, with sufficiently long
and strong exogenous stimulus to turn on the second switch,
TGF-b can be produced endogenously, allowing the switch
to remain at the on-state even after removing exogenous
TGF-b.
Each switch is composed of a double-negative feedback
loop mediated with miRNAs. This network motif is known
for generating delayed responses (40). The delay is further
facilitated by the long time required to remove the inhibiting
miRNAs, which have very long half-life and their concen-
trations are mainly reduced by cell-division-related dilution.
The delayed responses serve as low-pass filters to prevent
unregulated cell phenotypic transitions due to transient
TGF-b concentration fluctuations within the in vivo micro-
environment surrounding a cell.
Due to intrinsic and extrinsic noises, we predict that
EMT shows stochastic transition dynamics with a broad dis-
tribution of the transition time and varying sensitivity toBiophysical Journal 105(4) 1079–1089
FIGURE 8 Schematic depiction of the mechanism of EMT. In epithelial
cells, expression of SNAIL1 and ZEB is inhibited by miR-34 and miR-200,
respectively. Under treatment of exogenous TGF-b, cells first transit into a
partial EMT state by the first reversible bistable switch, which is governed
by the SNAIL1/miR-34 double-negative feedback loop. Then if the strength
and duration of treatment are large enough, cells transit to the mesenchymal
state by the second irreversible bistable switch, which is governed by ZEB/
miR-200 and the autocrine expression of TGF-b. Shown for each molecular
species (node): (dark-shaded box) high expression level; (light-shaded box)
low expression level; whereas(solid lines) activated regulation; (dashed
lines) inactivated regulation.
1086 Tian et al.TGF-b. The population relaxation in Fig. 7 C is slower
than an exponential decay process, which is analogous to
the dynamics disorder phenomenon observed in macromol-
ecule dynamics (41,42). This heterogeneous response
within a population may have evolutionary advantage
for generating an even broader response spectrum and pre-
venting exhaustion of the whole population with a single
stimulation.Our model analyses make several experimentally
testable predictions
Although seemingly simple, the regulatory network shown
in Fig. 1 gives rise to complex dynamic features. TheoreticalTABLE 1 Summary of predictions and experimental support of sim
Description
EMT is a sequential two-step program, with two distinct phases in EMT (initia
Partial EMT retains incomplete decrease of the epithelial marker and also show
Short-term TGF-b treatment causes a partial, reversible EMT (pEMT).
Complete EMT requires minimal strength and duration of TGF-b treatment.
SNAIL1 is uniquely required for the initiation of TGF-b-induced EMT, and an
pathway.
TGF-b induces EMT via upregulation of SNAIL1 at early states of the transitio
mesenchymal, migratory phenotype.
SNAIL1 initiates the repression of E-cadherin expression, and ZEB is required
Two-phasic behavior is governed by a cascade process of one reversible and on
The SNAIL1/miR-34 double-negative feedback loop is responsible for the first
The ZEB/miR-200 double-negative feedback loop is accountable for the second
Release of the miR-200-mediated inhibition on autocrine TGF-b makes the com
Biophysical Journal 105(4) 1079–1089analysis as done in this work provides essential guidance for
experimental studies on the structure-function relations of
the network. Table 1 summarizes the published experi-
mental reports that are qualitatively consistent with our
simulation results, but more systematic quantitative mea-
surements are necessary. Furthermore, several important
new testable predictions await confirmation. Below we sug-
gest a list of experimental studies.
First, in Fig. 2 we predict that at intermediate exogenous
TGF-b concentration, concentrations of the molecular spe-
cies associated with the first switch, but not those of the
second switch, change significantly, whereas at high exoge-
nous TGF-b concentration, the two switches turn on in
sequence. Existing studies only report the time course of
E-cadherin or N-cadherin, and the data points are too sparse
to unambiguously tell the predicted biphasic dynamics.
Therefore, detailed quantitative time-course and steady-
state measurements on multiple involved molecular species
are necessary for characterizing the system dynamics and
unraveling its mechanism.
Second, the bifurcation diagrams shown in Fig. 3 A and
Fig. 5 A and the result in Fig. 7 can be tested using some
standard procedures. Through slowly varying the exoge-
nous TGF-b concentration as indicated in Fig. 3 A, the
model predicts that the N-cadherin level (which can be
measured by methods such as Western blot) shows hystere-
sis—that is, at a given exogenous TGF-b concentration
within a bistable region, the N-cadherin level is different
depending on whether the cells are originally prepared
with low or high exogenous TGF-b concentrations. This
procedure follows that used in the classical studies of Sha
et al. (43) and Pomerening et al. (44) to confirm the bistable
cell-cycle transitions in Xenopus laevis egg extracts pre-
dicted by the Tyson-Novak model (45). The hysteretic
dynamics predicted in Fig. 5 A can be tested similarly.
More directly, the multimodal distributions predicted in
Fig. 7 can be tested with flow cytometry, which have
been used in other studies demonstrating multistability of
cellular systems (33). Microfluidic devices in combination
with some fluorescence labeling may facilitate systematiculation results
Ref.
tion and maintenance). (58)
s features of the mesenchymal marker. (59)
(11,60,61)
(11)
essential early mediator of activation of the ZEB/miR-200 (51,58)
n while subsequent expression of ZEB maintains the (51,62)
for the completed inhibition. (17,63)
e irreversible bistable switch. Prediction
bistable reversible switch, and triggers the initiation of EMT. Prediction
bistable irreversible switch. Prediction
plete EMT irreversible. (11)
Modeling Epithelial to Mesenchymal Transition 1087measurements under different conditions, such as TGF-b
stimulation, with different values of strength and duration,
as predicted in Fig. 3 B. Further molecular interference,
such as siRNA, may test how varying strengths of different
interactions affects the reversibility of each switch, as pre-
dicted in Fig. 5 B and Fig. 6 B. The new experimental
data can then be fed into the mathematical model for further
analysis.
Third, our numerical analysis suggests possible missing
regulation mechanism for miRNAs. Studies show that
miRNAs are very stable and have a bare half-life of
~120 h (46). Therefore, change of the cellular concentra-
tion of miRNAs is mainly due to cell division and growth-
related dilution, which gives an effective half-life of one
cell-cycle time. We use this half-life time in all the results
reported in the main text. However, the MCF10A data
shown in Fig. S1 reveals a much faster dynamics. We
have to use a smaller half-life of miRNAs, ~5 h, to repro-
duce the data. We thus suggest the dynamics of miRNAs
may be regulated by additional mechanisms not reported
for this system. Possible mechanisms include some post-
transcriptional regulated degradation of miRNAs (47) or
competitive inhibition of miRNAs (48). Alternatively,
another pathway other than miRNAs may exist to regulate
SNAIL1 and E-cadherin expression and responses to
TGF-b. Explicit time course measurements of the miRNAs,
as shown in Fig. S1, will help on clarifying this seemingly
controversy.Several directions exist on future computational/
experimental studies
The regulation of EMT is controlled in several layers
including the transcription, translation, post-translation,
the noncoding RNA, the stability, and the subcellular local-
ization (49). Recent evidence shows that epigenetic changes
across the genome also occur during EMT (50), and pro-
longed treatment of TGF-b leads to DNA hypermethylation
of the miR-200 promoters (11). Here, we only focus on the
transcriptional, translational, and noncoding RNA layers,
and leave inclusion of other layers for future studies.
In this work we only consider the core regulatory
network, and other regulators in EMT are not treated here,
such as Smad (21), Twist (51), and other microRNAs (5).
These regulators are either the upstream of SNAIL1/ZEB
or more cell-dependent than that of SNAIL1 and ZEB.
Furthermore, several other signaling pathways, such as
Wnt, Notch, and Ras-MAPK, can cooperate with TGF-b
to induce EMT (3). It is an interesting and important ques-
tion how these factors and pathways work cooperatively to
regulate the dynamics of EMT.
When endogenous TGF-b molecules are induced and
secreted out of cells, the extracellular TGF-b in the local
cellular environment increases, inducing EMT from more
cells. That is, there is some autoactivation effect among cellsat the tissue level. In this work we assume that TGF-b diffu-
sion is fast at the experimental culturing conditions, and thus
the extracellular TGF-b concentration is uniform. At the
tissue level where cells are densely packed in three dimen-
sions, some TGF-b gradient may be established. It is
interesting to investigate this effect and its physiological
consequences by building a spatial model with cell-cell
communication combined with other, related experimental
studies in the future.
Reports exist that the miR-200 and miR-34 are targets of
the tumor suppressor p53 (52). That is, both ZEB/miR-200
and SNAIL1/miR-34 double-negative feedback loops are
regulated by p53. Thus, in addition to the conventional roles
of regulating cell cycle arrest, senescence, and apoptosis,
p53 has a regulating role in controlling EMT-MET plas-
ticity. Because inappropriate occurrence of EMT leads to
cancer metastasis (49,53), it is interesting to explore the
role of p53 in cancer metastasis through regulating EMT.
It also reported that EMT is regulated by the PI3K/PTEN/
AKT pathway through Twist and Snail (54), and the
PI3K/PTEN/AKT pathway also plays an important role in
cell-fate decision when coupled with the p53 signaling
pathway (55,56). In addition, various reports show that the
ZEB family also links EMT with cell cycle control,
apoptosis, and senescence (57). Thus, another important
question to be answered is how cell fates are decided among
EMT, apoptosis, and cell cycle arrest.
The reverse process of EMT, MET, is a key step in cell
reprogramming. It has been shown that MET is the first
step during the reprogramming of mouse fibroblasts into
iPSCs by exogenous factors OSKM (Oct4, Sox2, Klf4,
Myc), which suppress TGF-b signaling (36). It also has
been shown that BMP-dependent activation of miR-200
cooperates with OSKM, which drives MET during the initi-
ation phase of reprogramming of mouse fibroblasts (37).
Recently, it is found that Oct4/Sox2 can also directly acti-
vate miR-200 (38). As the reverse process of MET, the
mechanism of EMT presented here may provide clues for
improving the efficiency of cell reprogramming. Further-
more, EMT is associated with stemness properties and is
potentially involved in cancer stem cells, because stem
cell factors, such as Sox2 and Klf4, are also candidate
targets of the miR-200 family (6). Understanding the under-
lying mechanism will give some ideas for effective thera-
peutic strategy to prevent tumor metastasis.SUPPORTING MATERIAL
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